Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ355LO2W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W 0.8 %
2W 0.5 %
1M 0.0 %
3M -5.4 %
6M -5.4 %
9M 3.2 %
1Y 0.5 %
Alpha
-6.2%
Beta
0.26
sharpe-R
0.06
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:35
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -9.91%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 5.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
4
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-12 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 20.69% 3.96%
The percentage of cash held in the portfolio is: 79.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -5.21%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 19.38% -2.65%
PODD Insulet Corporation Buy 20.14% 1.11%
The percentage of cash held in the portfolio is: 60.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 19.01% -4.2%
NEOG Neogen Corporation Buy 19.42% -2.15%
PODD Insulet Corporation Buy 19.86% 0%
The percentage of cash held in the portfolio is: 41.71%
New Assets Added
  • PODD
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 19.5% -0.64%
NEOG Neogen Corporation Buy 19.63% 0%
The percentage of cash held in the portfolio is: 60.88%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • APLS
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 5.88%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.66% 2.5%
The percentage of cash held in the portfolio is: 80.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All -1.15%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 20.92% -1%
RMD ResMed Inc. Buy 19.27% 0%
The percentage of cash held in the portfolio is: 59.81%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 20.48% -0.19%
CLDX Celldex Therapeutics, Inc. Buy 20.07% 1.6%
The percentage of cash held in the portfolio is: 59.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRC AtriCure, Inc. Buy 18.95% -7%
RCM R1 RCM Inc. Buy 20.2% -0.84%
CLDX Celldex Therapeutics, Inc. Buy 19.62% 0%
The percentage of cash held in the portfolio is: 41.24%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRC AtriCure, Inc. Buy 19.18% -5.18%
RCM R1 RCM Inc. Buy 20.41% 0.92%
The percentage of cash held in the portfolio is: 60.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Sell All -11.55%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
SAGE Sage Therapeutics, Inc. Buy 20.19% 3.54%
ATRC AtriCure, Inc. Buy 19.32% -0.91%
RCM R1 RCM Inc. Buy 19.5% 0%
The percentage of cash held in the portfolio is: 40.99%
New Assets Added
  • RCM
Assets Removed
None
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
SAGE Sage Therapeutics, Inc. Buy 20.17% 3.62%
ATRC AtriCure, Inc. Buy 19.46% 0%
The percentage of cash held in the portfolio is: 60.37%
New Assets Added
  • ATRC
Assets Removed
None
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
SAGE Sage Therapeutics, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • SAGE
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACAD Sell All 2.77%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 19.24% -1.83%
The percentage of cash held in the portfolio is: 80.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 19.32% -1.76%
STAA STAAR Surgical Company Buy 19.67% 0%
The percentage of cash held in the portfolio is: 61.01%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ACAD
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -3.3%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.92% -0.47%
The percentage of cash held in the portfolio is: 80.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -7.87%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.45% -1.26%
PODD Insulet Corporation Buy 19.89% 1.02%
The percentage of cash held in the portfolio is: 60.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 1.03%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 19.81% 5.08%
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.81% 1.73%
PODD Insulet Corporation Buy 19.46% 0%
The percentage of cash held in the portfolio is: 40.92%
New Assets Added
  • PODD
Assets Removed
None
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 18.97% -0.86%
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.76% 0%
The percentage of cash held in the portfolio is: 61.27%
New Assets Added
  • BCRX
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 19.1% -0.03%
The percentage of cash held in the portfolio is: 80.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 12.88%
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 21.98% 15.54%
OMCL Omnicell, Inc. Buy 19.01% 0%
The percentage of cash held in the portfolio is: 59.02%
New Assets Added
  • OMCL
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • PTCT
Assets Removed
None
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -2.07%
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • TNDM
Assets Removed
None
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
BAX Sell All -2.7%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 18.5% -3.37%
The percentage of cash held in the portfolio is: 81.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All -7.19%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 18.44% -3.21%
RCM R1 RCM Inc. Buy 18.14% -4.72%
The percentage of cash held in the portfolio is: 63.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 4.78%
NTRA Sell All 0.12%
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 20.87% 2.95%
NTRA Natera, Inc. Buy 20.24% -0.15%
BAX Baxter International Inc. Buy 19.06% 1.14%
RCM R1 RCM Inc. Buy 18.64% -1.06%
The percentage of cash held in the portfolio is: 21.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
KRYS Sell All 8.53%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
KRYS Krystal Biotech, Inc. Buy 18.91% 7.95%
THC Tenet Healthcare Corporation Buy 20.92% 4.1%
NTRA Natera, Inc. Buy 20.6% 2.52%
BAX Baxter International Inc. Buy 18.89% 1.16%
RCM R1 RCM Inc. Buy 18.67% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
None
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
KRYS Krystal Biotech, Inc. Buy 19.49% 11.06%
THC Tenet Healthcare Corporation Buy 20.78% 3.23%
NTRA Natera, Inc. Buy 20.31% 0.91%
BAX Baxter International Inc. Buy 18.71% 0%
The percentage of cash held in the portfolio is: 20.71%
New Assets Added
  • BAX
Assets Removed
None
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
KRYS Krystal Biotech, Inc. Buy 19.36% 8.82%
THC Tenet Healthcare Corporation Buy 20.68% 1.35%
NTRA Natera, Inc. Buy 20% -2%
The percentage of cash held in the portfolio is: 39.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
BPMC Sell All -1.73%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BPMC Blueprint Medicines Corporation Buy 18.45% 4.24%
KRYS Krystal Biotech, Inc. Buy 18.86% 6.89%
THC Tenet Healthcare Corporation Buy 20.23% 0%
NTRA Natera, Inc. Buy 20.23% 0%
The percentage of cash held in the portfolio is: 22.23%
New Assets Added
  • THC
  • NTRA
Assets Removed
Asset Action Perf %
RARE Sell All 9.75%
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 19.07% 5.72%
BPMC Blueprint Medicines Corporation Buy 18.5% 2.49%
KRYS Krystal Biotech, Inc. Buy 18.28% 1.57%
The percentage of cash held in the portfolio is: 44.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 25.78%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 22.84% 28.83%
RARE Ultragenyx Pharmaceutical Inc. Buy 19.12% 7.83%
BPMC Blueprint Medicines Corporation Buy 18.56% 4.6%
KRYS Krystal Biotech, Inc. Buy 18.38% 3.87%
The percentage of cash held in the portfolio is: 21.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 8.03%
Assets Rebalanced
None
2024-02-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 19.11% 4.43%
RCM R1 RCM Inc. Buy 22.76% 24.35%
RARE Ultragenyx Pharmaceutical Inc. Buy 18.8% 2.72%
BPMC Blueprint Medicines Corporation Buy 19.08% 4.16%
KRYS Krystal Biotech, Inc. Buy 18.26% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • KRYS
Assets Removed
Asset Action Perf %
IART Sell All 0.5%
Assets Rebalanced
None
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 20.23% 2.89%
BRKR Bruker Corporation Buy 19.92% 1.31%
RCM R1 RCM Inc. Buy 18.95% -3.58%
RARE Ultragenyx Pharmaceutical Inc. Buy 19.23% -2.15%
BPMC Blueprint Medicines Corporation Buy 19.67% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BPMC
Assets Removed
None
Assets Rebalanced
None
2024-02-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 20.01% 2.53%
BRKR Bruker Corporation Buy 19.95% 2.21%
RCM R1 RCM Inc. Buy 18.99% -2.69%
RARE Ultragenyx Pharmaceutical Inc. Buy 19.52% 0%
The percentage of cash held in the portfolio is: 21.52%
New Assets Added
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 19.89% 1.87%
BRKR Bruker Corporation Buy 19.54% 0.06%
RCM R1 RCM Inc. Buy 19.52% 0%
The percentage of cash held in the portfolio is: 41.05%
New Assets Added
  • RCM
Assets Removed
None
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 19.5% -0.64%
BRKR Bruker Corporation Buy 19.63% 0%
The percentage of cash held in the portfolio is: 60.88%
New Assets Added
  • BRKR
Assets Removed
None
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • IART
Assets Removed
None
Assets Rebalanced
None
2023-12-01 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
LNTH Sell All 5.09%
Assets Rebalanced
None
2023-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
LNTH Lantheus Holdings, Inc. Buy 19.93% 1.23%
The percentage of cash held in the portfolio is: 80.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 13.68%
Assets Rebalanced
None
2023-11-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 20.61% 13.21%
LNTH Lantheus Holdings, Inc. Buy 19.74% -0.04%
The percentage of cash held in the portfolio is: 59.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMRN Sell All 3.01%
Assets Rebalanced
None
2023-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 17.54% 2.37%
THC Tenet Healthcare Corporation Buy 20.02% 9.03%
LNTH Lantheus Holdings, Inc. Buy 19.93% 0.07%
The percentage of cash held in the portfolio is: 42.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALNY Sell All -2.16%
IQV Sell All 3.85%
Assets Rebalanced
None
2023-11-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.54% 0.97%
IQV IQVIA Holdings Inc. Buy 21.12% 3.85%
BMRN BioMarin Pharmaceutical Inc. Buy 17.69% 2.01%
THC Tenet Healthcare Corporation Buy 18.48% -0.55%
LNTH Lantheus Holdings, Inc. Buy 20.16% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • LNTH
Assets Removed
Asset Action Perf %
RMD Sell All -0.8%
Assets Rebalanced
None
2023-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 20.15% -1.86%
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.85% 1.58%
IQV IQVIA Holdings Inc. Buy 20.87% 1.66%
BMRN BioMarin Pharmaceutical Inc. Buy 17.37% -0.74%
THC Tenet Healthcare Corporation Buy 18.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • THC
Assets Removed
None
Assets Rebalanced
None
2023-11-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 20.08% -4.45%
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.66% -1.69%
IQV IQVIA Holdings Inc. Buy 20.45% -2.68%
BMRN BioMarin Pharmaceutical Inc. Buy 17.55% -2.07%
The percentage of cash held in the portfolio is: 21.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYTK Sell All -8.84%
Assets Rebalanced
None
2023-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 20.14% 0.11%
CYTK Cytokinetics, Incorporated Buy 19.85% -1.29%
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.46% 1.7%
IQV IQVIA Holdings Inc. Buy 20.41% 1.46%
BMRN BioMarin Pharmaceutical Inc. Buy 17.15% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BMRN
Assets Removed
None
Assets Rebalanced
None
2023-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 20.8% 2.52%
CYTK Cytokinetics, Incorporated Buy 19.23% -5.2%
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.26% -0.12%
IQV IQVIA Holdings Inc. Buy 20.41% 0.61%
The percentage of cash held in the portfolio is: 19.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
KRYS Sell All -15.05%
Assets Rebalanced
None
2023-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.88% 1.81%
CYTK Cytokinetics, Incorporated Buy 19.53% 0%
KRYS Krystal Biotech, Inc. Buy 19.53% 0%
ALNY Alnylam Pharmaceuticals, Inc. Buy 19.53% 0%
IQV IQVIA Holdings Inc. Buy 19.53% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CYTK
  • KRYS
  • ALNY
  • IQV
Assets Removed
None
Assets Rebalanced
None
2023-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • RMD
Assets Removed
None
Assets Rebalanced
None
2023-10-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All -11.44%
Assets Rebalanced
None
2023-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Buy 18.84% -4.71%
The percentage of cash held in the portfolio is: 81.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRTX Sell All 0.34%
Assets Rebalanced
None
2023-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 20.16% 3.57%
STAA STAAR Surgical Company Buy 19.46% 0%
The percentage of cash held in the portfolio is: 60.38%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
None
2023-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • VRTX
Assets Removed
None
Assets Rebalanced
None
2023-09-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CNC Sell All 4.67%
Assets Rebalanced
None
2023-09-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CNC Centene Corporation Buy 20.18% 2.47%
The percentage of cash held in the portfolio is: 79.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 2.34%
Assets Rebalanced
None
2023-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 20.17% 2.31%
CNC Centene Corporation Buy 20.13% 2.12%
The percentage of cash held in the portfolio is: 59.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All -7.33%
Assets Rebalanced
None
2023-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 19.76% 0.99%
CNC Centene Corporation Buy 19.55% -0.03%
STAA STAAR Surgical Company Buy 19.56% 0%
The percentage of cash held in the portfolio is: 41.13%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
None
2023-09-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 20.06% 2.93%
CNC Centene Corporation Buy 19.49% 0%
The percentage of cash held in the portfolio is: 60.46%
New Assets Added
  • CNC
Assets Removed
None
Assets Rebalanced
None
2023-09-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-09-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
IONS Sell All -3.72%
Assets Rebalanced
None
2023-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IONS Ionis Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • IONS
Assets Removed
None
Assets Rebalanced
None
2023-08-16 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All 1.72%
Assets Rebalanced
None
2023-08-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 20.56% 0.77%
The percentage of cash held in the portfolio is: 79.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 3.18%
Assets Rebalanced
None
2023-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 20.32% -1.43%
INSM Insmed Incorporated Buy 20.53% -0.63%
The percentage of cash held in the portfolio is: 59.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALGN Sell All -6.2%
Assets Rebalanced
None
2023-08-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.36% -4.95%
HQY HealthEquity, Inc. Buy 20.87% 2.46%
INSM Insmed Incorporated Buy 20.43% 0.09%
The percentage of cash held in the portfolio is: 39.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All -5.15%
Assets Rebalanced
None
2023-08-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.54% -4.65%
ICUI ICU Medical, Inc. Buy 19.73% -3.75%
HQY HealthEquity, Inc. Buy 20.4% -0.44%
INSM Insmed Incorporated Buy 20.2% -1.63%
The percentage of cash held in the portfolio is: 20.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Sell All -11.76%
Assets Rebalanced
None
2023-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.6% -2.26%
ICUI ICU Medical, Inc. Buy 19.66% -1.95%
TDOC Teladoc Health, Inc. Buy 18.69% -6.79%
HQY HealthEquity, Inc. Buy 19.95% -0.53%
INSM Insmed Incorporated Buy 20.09% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INSM
Assets Removed
None
Assets Rebalanced
None
2023-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.3% -1.93%
ICUI ICU Medical, Inc. Buy 19.68% 0%
TDOC Teladoc Health, Inc. Buy 19.68% 0%
HQY HealthEquity, Inc. Buy 19.68% 0%
The percentage of cash held in the portfolio is: 21.68%
New Assets Added
  • ICUI
  • TDOC
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-07-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2023-06-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -4.13%
Assets Rebalanced
None
2023-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-05-16 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMRN Sell All -1.86%
Assets Rebalanced
None
2023-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • BMRN
Assets Removed
None
Assets Rebalanced
None
2023-04-27 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -4.78%
Assets Rebalanced
None
2023-04-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 18.86% -2.36%
The percentage of cash held in the portfolio is: 81.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Sell All 7.08%
ALGN Sell All 2.43%
Assets Rebalanced
None
2023-04-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGRY Surgery Partners, Inc. Buy 20.64% 7.25%
ALGN Align Technology, Inc. Buy 19.66% 2.16%
MASI Masimo Corporation Buy 19.23% 0%
The percentage of cash held in the portfolio is: 40.47%
New Assets Added
  • MASI
Assets Removed
None
Assets Rebalanced
None
2023-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGRY Surgery Partners, Inc. Buy 19.6% 0%
ALGN Align Technology, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • SGRY
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2023-02-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 5.17%
Assets Rebalanced
None
2023-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 19.67% -3.35%
The percentage of cash held in the portfolio is: 80.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -8.36%
PKI Sell All -5.28%
Assets Rebalanced
None
2023-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 19.3% -2.05%
PKI PerkinElmer, Inc. Buy 19.04% -3.38%
HQY HealthEquity, Inc. Buy 19.89% 0%
The percentage of cash held in the portfolio is: 41.77%
New Assets Added
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 19.59% 0.13%
PKI PerkinElmer, Inc. Buy 19.2% -1.82%
The percentage of cash held in the portfolio is: 61.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
EXEL Sell All 4.9%
Assets Rebalanced
None
2023-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
EXEL Exelixis, Inc. Buy 20.07% 5.26%
TNDM Tandem Diabetes Care, Inc. Buy 19.48% 0%
PKI PerkinElmer, Inc. Buy 19.48% 0%
The percentage of cash held in the portfolio is: 40.97%
New Assets Added
  • TNDM
  • PKI
Assets Removed
None
Assets Rebalanced
None
2023-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
EXEL Exelixis, Inc. Buy 20.16% 5.86%
The percentage of cash held in the portfolio is: 79.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
HUM Sell All 1.03%
ISEE Sell All 7.69%
Assets Rebalanced
None
2023-01-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 19.47% 1.23%
ISEE IVERIC bio, Inc. Buy 20.05% 4.24%
EXEL Exelixis, Inc. Buy 19.96% 3.77%
The percentage of cash held in the portfolio is: 40.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRTC Sell All 0.41%
Assets Rebalanced
None
2023-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRTC iRhythm Technologies, Inc. Buy 19.72% 0.92%
HUM Humana Inc. Buy 19.65% 0.61%
ISEE IVERIC bio, Inc. Buy 19.55% 0.05%
EXEL Exelixis, Inc. Buy 19.54% 0%
The percentage of cash held in the portfolio is: 21.54%
New Assets Added
  • EXEL
Assets Removed
None
Assets Rebalanced
None
2023-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRTC iRhythm Technologies, Inc. Buy 20.22% 3.95%
HUM Humana Inc. Buy 19.45% 0%
ISEE IVERIC bio, Inc. Buy 19.45% 0%
The percentage of cash held in the portfolio is: 40.89%
New Assets Added
  • HUM
  • ISEE
Assets Removed
None
Assets Rebalanced
None
2023-01-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRTC iRhythm Technologies, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • IRTC
Assets Removed
None
Assets Rebalanced
None
2022-12-05 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All -0.77%
Assets Rebalanced
None
2022-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ICUI ICU Medical, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ICUI
Assets Removed
None
Assets Rebalanced
None
2022-11-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CRL Sell All -4.23%
Assets Rebalanced
None
2022-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CRL Charles River Laboratories International, Inc. Buy 18.79% -3.17%
The percentage of cash held in the portfolio is: 81.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
WAT Sell All 5.27%
Assets Rebalanced
None
2022-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
WAT Waters Corporation Buy 21.27% 8.1%
CRL Charles River Laboratories International, Inc. Buy 19.18% 0%
The percentage of cash held in the portfolio is: 59.55%
New Assets Added
  • CRL
Assets Removed
None
Assets Rebalanced
None
2022-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
WAT Waters Corporation Buy 20.06% 0.46%
The percentage of cash held in the portfolio is: 79.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
ILMN Sell All -1.53%
Assets Rebalanced
None
2022-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ILMN Illumina, Inc. Buy 18.51% 1.72%
WAT Waters Corporation Buy 19.87% 0%
The percentage of cash held in the portfolio is: 61.62%
New Assets Added
  • WAT
Assets Removed
None
Assets Rebalanced
None
2022-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ILMN Illumina, Inc. Buy 17.6% -4.35%
The percentage of cash held in the portfolio is: 82.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
ZBH Sell All -4.99%
Assets Rebalanced
None
2022-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ILMN Illumina, Inc. Buy 18.63% 3.74%
ZBH Zimmer Biomet Holdings, Inc. Buy 19.84% 0%
The percentage of cash held in the portfolio is: 61.53%
New Assets Added
  • ZBH
Assets Removed
Asset Action Perf %
UNH Sell All 6.38%
Assets Rebalanced
None
2022-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
UNH UnitedHealth Group Incorporated Buy 18.84% 5.63%
ILMN Illumina, Inc. Buy 18.93% 5.64%
The percentage of cash held in the portfolio is: 62.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
IQV Sell All 20.04%
Assets Rebalanced
None
2022-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IQV IQVIA Holdings Inc. Buy 20.83% 15.58%
UNH UnitedHealth Group Incorporated Buy 18.67% 3.82%
ILMN Illumina, Inc. Buy 19.4% 7.39%
The percentage of cash held in the portfolio is: 41.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
UTHR Sell All 5.64%
Assets Rebalanced
None
2022-10-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
UTHR United Therapeutics Corporation Buy 19.11% 6.52%
IQV IQVIA Holdings Inc. Buy 20.92% 16.54%
UNH UnitedHealth Group Incorporated Buy 18.64% 4.08%
ILMN Illumina, Inc. Buy 19.35% 7.6%
The percentage of cash held in the portfolio is: 21.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
CLDX Sell All 11.9%
Assets Rebalanced
None
2022-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CLDX Celldex Therapeutics, Inc. Buy 19.9% 4.75%
UTHR United Therapeutics Corporation Buy 19.73% 3.9%
IQV IQVIA Holdings Inc. Buy 19.67% 3.55%
UNH UnitedHealth Group Incorporated Buy 19.67% 3.78%
ILMN Illumina, Inc. Buy 19.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ILMN
Assets Removed
None
Assets Rebalanced
None
2022-10-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CLDX Celldex Therapeutics, Inc. Buy 20.04% 5.08%
UTHR United Therapeutics Corporation Buy 19.56% 2.63%
IQV IQVIA Holdings Inc. Buy 20.26% 6.3%
UNH UnitedHealth Group Incorporated Buy 19.03% 0.06%
The percentage of cash held in the portfolio is: 21.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Sell All 0.29%
Assets Rebalanced
None
2022-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 18.66% -2.43%
CLDX Celldex Therapeutics, Inc. Buy 20.42% 6.75%
UTHR United Therapeutics Corporation Buy 19.86% 3.85%
IQV IQVIA Holdings Inc. Buy 19.98% 4.48%
UNH UnitedHealth Group Incorporated Buy 19.08% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UNH
Assets Removed
None
Assets Rebalanced
None
2022-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 18.88% -3.55%
CLDX Celldex Therapeutics, Inc. Buy 20.17% 3.05%
UTHR United Therapeutics Corporation Buy 19.81% 1.25%
IQV IQVIA Holdings Inc. Buy 19.57% 0%
The percentage of cash held in the portfolio is: 21.57%
New Assets Added
  • IQV
Assets Removed
None
Assets Rebalanced
None
2022-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 19.16% -1.58%
CLDX Celldex Therapeutics, Inc. Buy 20.45% 5.05%
UTHR United Therapeutics Corporation Buy 19.46% 0%
The percentage of cash held in the portfolio is: 40.92%
New Assets Added
  • UTHR
Assets Removed
None
Assets Rebalanced
None
2022-10-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 19.11% -3.06%
CLDX Celldex Therapeutics, Inc. Buy 19.72% 0%
The percentage of cash held in the portfolio is: 61.16%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2022-10-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • AMN
Assets Removed
None
Assets Rebalanced
None
2022-07-25 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALGN Sell All 1.67%
Assets Rebalanced
None
2022-07-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.93% 2.21%
The percentage of cash held in the portfolio is: 80.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACHC Sell All 7.44%
Assets Rebalanced
None
2022-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACHC Acadia Healthcare Company, Inc. Buy 20.15% 1.96%
ALGN Align Technology, Inc. Buy 19.05% -4.6%
The percentage of cash held in the portfolio is: 60.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
ZBH Sell All -4.8%
Assets Rebalanced
None
2022-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ZBH Zimmer Biomet Holdings, Inc. Buy 18.86% -2.92%
ACHC Acadia Healthcare Company, Inc. Buy 20.26% 4.31%
ALGN Align Technology, Inc. Buy 19.63% 0%
The percentage of cash held in the portfolio is: 41.25%
New Assets Added
  • ALGN
Assets Removed
Asset Action Perf %
BIIB Sell All 3.24%
Assets Rebalanced
None
2022-07-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
BIIB Biogen Inc. Buy 19.71% 0.31%
ZBH Zimmer Biomet Holdings, Inc. Buy 19.35% -1.49%
ACHC Acadia Healthcare Company, Inc. Buy 19.65% 0%
The percentage of cash held in the portfolio is: 41.29%
New Assets Added
  • ACHC
Assets Removed
None
Assets Rebalanced
None
2022-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
BIIB Biogen Inc. Buy 19.72% 0.77%
ZBH Zimmer Biomet Holdings, Inc. Buy 19.57% 0%
The percentage of cash held in the portfolio is: 60.71%
New Assets Added
  • ZBH
Assets Removed
None
Assets Rebalanced
None
2022-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
BIIB Biogen Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • BIIB
Assets Removed
None
Assets Rebalanced
None
2022-06-15 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
FOLD Sell All -5.93%
Assets Rebalanced
None
2022-06-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 19.97% -0.95%
The percentage of cash held in the portfolio is: 80.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Sell All -11.27%
BCRX Sell All 1.02%
EVH Sell All -7.67%
Assets Rebalanced
None
2022-06-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 19.06% -2.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 21.65% 10.55%
EVH Evolent Health, Inc. Buy 19.03% -0.56%
FOLD Amicus Therapeutics, Inc. Buy 19.13% 0%
The percentage of cash held in the portfolio is: 21.13%
New Assets Added
  • FOLD
Assets Removed
None
Assets Rebalanced
None
2022-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 19.09% -3.24%
BCRX BioCryst Pharmaceuticals, Inc. Buy 21.05% 6.66%
EVH Evolent Health, Inc. Buy 19.29% 0%
The percentage of cash held in the portfolio is: 40.57%
New Assets Added
  • EVH
Assets Removed
None
Assets Rebalanced
None
2022-06-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 18.56% -8.81%
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.69% -3.28%
The percentage of cash held in the portfolio is: 61.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
TECH Sell All -6.88%
Assets Rebalanced
None
2022-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 19.6% 0%
TECH Bio-Techne Corporation Buy 19.6% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 41.2%
New Assets Added
  • TDOC
  • TECH
  • BCRX
Assets Removed
None
Assets Rebalanced
None
2022-05-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACHC Sell All -5.73%
Assets Rebalanced
None
2022-05-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACHC Acadia Healthcare Company, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ACHC
Assets Removed
None
Assets Rebalanced
None
2022-04-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYTK Sell All -4.47%
Assets Rebalanced
None
2022-04-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYTK Cytokinetics, Incorporated Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • CYTK
Assets Removed
None
Assets Rebalanced
None
2022-04-04 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CAH Sell All 0.54%
DXCM Sell All 13.57%
Assets Rebalanced
None
2022-04-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CAH Cardinal Health, Inc. Buy 18.95% -1.03%
DXCM DexCom, Inc. Buy 20.93% 9.3%
The percentage of cash held in the portfolio is: 60.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
TECH Sell All 0.3%
Assets Rebalanced
None
2022-03-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
TECH Bio-Techne Corporation Buy 19.42% 2.47%
CAH Cardinal Health, Inc. Buy 19.07% 0.59%
DXCM DexCom, Inc. Buy 21.02% 10.89%
The percentage of cash held in the portfolio is: 40.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Sell All 3.26%
Assets Rebalanced
None
2022-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 20.04% 3.63%
TECH Bio-Techne Corporation Buy 19.96% 3.21%
CAH Cardinal Health, Inc. Buy 19.33% 0%
DXCM DexCom, Inc. Buy 19.33% 0%
The percentage of cash held in the portfolio is: 21.33%
New Assets Added
  • CAH
  • DXCM
Assets Removed
None
Assets Rebalanced
None
2022-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 20.36% 4.87%
TECH Bio-Techne Corporation Buy 19.41% 0%
The percentage of cash held in the portfolio is: 60.23%
New Assets Added
  • TECH
Assets Removed
None
Assets Rebalanced
None
2022-03-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • AMN
Assets Removed
None
Assets Rebalanced
None
2022-03-14 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
IART Sell All -3.35%
CYTK Sell All 7.08%
Assets Rebalanced
None
2022-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 20.04% -2.33%
CYTK Cytokinetics, Incorporated Buy 22.19% 8.14%
The percentage of cash held in the portfolio is: 57.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Sell All -15.57%
Assets Rebalanced
None
2022-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 18.73% -7.15%
IART Integra LifeSciences Holdings Corporation Buy 20.3% 0.67%
CYTK Cytokinetics, Incorporated Buy 21.21% 5.17%
The percentage of cash held in the portfolio is: 39.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
COO Sell All -2.36%
SAGE Sell All -10.7%
Assets Rebalanced
None
2022-02-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
COO The Cooper Companies, Inc. Buy 19.6% 0%
AMN AMN Healthcare Services, Inc. Buy 19.6% 0%
IART Integra LifeSciences Holdings Corporation Buy 19.6% 0%
CYTK Cytokinetics, Incorporated Buy 19.6% 0%
SAGE Sage Therapeutics, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • COO
  • AMN
  • IART
  • CYTK
  • SAGE
Assets Removed
None
Assets Rebalanced
None
2022-02-25 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SEM Sell All 0%
Assets Rebalanced
None
2022-02-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
SEM Select Medical Holdings Corporation Buy 19.51% -0.72%
The percentage of cash held in the portfolio is: 80.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
DNLI Sell All -12.8%
Assets Rebalanced
None
2022-02-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
DNLI Denali Therapeutics Inc. Buy 17.79% -7.87%
SEM Select Medical Holdings Corporation Buy 19.88% 2.89%
The percentage of cash held in the portfolio is: 62.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 0.16%
Assets Rebalanced
None
2022-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.18% -0.82%
DNLI Denali Therapeutics Inc. Buy 17.96% -7.07%
SEM Select Medical Holdings Corporation Buy 19.85% 2.64%
The percentage of cash held in the portfolio is: 43.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
LNTH Sell All 12.08%
Assets Rebalanced
None
2022-02-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
LNTH Lantheus Holdings, Inc. Buy 20.8% 7.1%
RMD ResMed Inc. Buy 20.01% 3.01%
DNLI Denali Therapeutics Inc. Buy 18.35% -5.42%
SEM Select Medical Holdings Corporation Buy 19.42% 0%
The percentage of cash held in the portfolio is: 21.42%
New Assets Added
  • SEM
Assets Removed
None
Assets Rebalanced
None
2022-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
LNTH Lantheus Holdings, Inc. Buy 20.69% 8.03%
RMD ResMed Inc. Buy 19.9% 3.91%
DNLI Denali Therapeutics Inc. Buy 19.14% 0%
The percentage of cash held in the portfolio is: 40.27%
New Assets Added
  • DNLI
Assets Removed
None
Assets Rebalanced
None
2022-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
LNTH Lantheus Holdings, Inc. Buy 19.75% 0.93%
RMD ResMed Inc. Buy 19.56% 0%
The percentage of cash held in the portfolio is: 60.69%
New Assets Added
  • RMD
Assets Removed
None
Assets Rebalanced
None
2022-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
LNTH Lantheus Holdings, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • LNTH
Assets Removed
None
Assets Rebalanced
None
2022-01-03 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All 6.29%
Assets Rebalanced
None
2021-12-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
BCRX BioCryst Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • BCRX
Assets Removed
None
Assets Rebalanced
None
2021-11-17 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MCK Sell All 0.77%
ALNY Sell All 3.16%
Assets Rebalanced
None
2021-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
MCK McKesson Corporation Buy 19.62% 1.37%
ALNY Alnylam Pharmaceuticals, Inc. Buy 20.01% 3.38%
The percentage of cash held in the portfolio is: 60.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMY Sell All 1.6%
Assets Rebalanced
None
2021-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMY Bristol-Myers Squibb Company Buy 19.59% -0.09%
MCK McKesson Corporation Buy 19.6% 0%
ALNY Alnylam Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 41.21%
New Assets Added
  • MCK
  • ALNY
Assets Removed
None
Assets Rebalanced
None
2021-11-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMY Bristol-Myers Squibb Company Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • BMY
Assets Removed
None
Assets Rebalanced
None
2021-09-14 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All -7.59%
Assets Rebalanced
None
2021-08-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
None
2021-08-10 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALGN Sell All -1.33%
Assets Rebalanced
None
2021-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALGN Align Technology, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2021-06-25 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SYNH Sell All 2.63%
Assets Rebalanced
None
2021-06-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
SYNH Syneos Health, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • SYNH
Assets Removed
None
Assets Rebalanced
None
2021-06-08 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CRL Sell All 2.74%
Assets Rebalanced
None
2021-05-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CRL Charles River Laboratories International, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • CRL
Assets Removed
None
Assets Rebalanced
None
2021-05-13 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
UHS Sell All 4.25%
Assets Rebalanced
None
2021-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
UHS Universal Health Services, Inc. Buy 20% 4.99%
The percentage of cash held in the portfolio is: 80%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Sell All 13.05%
CNMD Sell All 8.02%
Assets Rebalanced
None
2021-05-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
AMN AMN Healthcare Services, Inc. Buy 19.87% 1.8%
CNMD CONMED Corporation Buy 21.26% 8.92%
UHS Universal Health Services, Inc. Buy 20.17% 3.48%
The percentage of cash held in the portfolio is: 38.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All -8.73%
Assets Rebalanced
None
2021-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 20.09% 4.25%
AMN AMN Healthcare Services, Inc. Buy 19.39% 0.63%
CNMD CONMED Corporation Buy 20.59% 6.86%
UHS Universal Health Services, Inc. Buy 19.33% 0.53%
The percentage of cash held in the portfolio is: 20.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
FOLD Sell All -3.48%
Assets Rebalanced
None
2021-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 19.19% -0.97%
RCM R1 RCM Inc. Buy 20.21% 4.44%
AMN AMN Healthcare Services, Inc. Buy 19.43% 0.44%
CNMD CONMED Corporation Buy 19.85% 2.59%
UHS Universal Health Services, Inc. Buy 19.32% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UHS
Assets Removed
None
Assets Rebalanced
None
2021-04-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 19.09% -3.1%
RCM R1 RCM Inc. Buy 19.89% 1.07%
AMN AMN Healthcare Services, Inc. Buy 19.67% 0%
CNMD CONMED Corporation Buy 19.67% 0%
The percentage of cash held in the portfolio is: 21.67%
New Assets Added
  • AMN
  • CNMD
Assets Removed
None
Assets Rebalanced
None
2021-04-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 18.91% -4.45%
RCM R1 RCM Inc. Buy 19.77% 0%
The percentage of cash held in the portfolio is: 61.31%
New Assets Added
  • RCM
Assets Removed
None
Assets Rebalanced
None
2021-04-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 18.96% -4.16%
The percentage of cash held in the portfolio is: 81.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
AZTA Sell All -0.4%
Assets Rebalanced
None
2021-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
AZTA Azenta, Inc. Buy 19.8% 1.46%
FOLD Amicus Therapeutics, Inc. Buy 19.55% 0%
The percentage of cash held in the portfolio is: 60.65%
New Assets Added
  • FOLD
Assets Removed
None
Assets Rebalanced
None
2021-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
AZTA Azenta, Inc. Buy 19.24% -2.09%
The percentage of cash held in the portfolio is: 80.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 7.04%
CLDX Sell All 8.11%
Assets Rebalanced
None
2021-04-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 20.91% 3.98%
CLDX Celldex Therapeutics, Inc. Buy 20.29% 0.92%
AZTA Azenta, Inc. Buy 19.48% -3.01%
The percentage of cash held in the portfolio is: 39.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
NTLA Sell All -14.76%
Assets Rebalanced
None
2021-04-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.36% 0.56%
NTLA Intellia Therapeutics, Inc. Buy 19.24% -0.03%
CLDX Celldex Therapeutics, Inc. Buy 20.94% 8.79%
AZTA Azenta, Inc. Buy 19.23% 0%
The percentage of cash held in the portfolio is: 21.23%
New Assets Added
  • AZTA
Assets Removed
None
Assets Rebalanced
None
2021-04-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 19.6% 0%
NTLA Intellia Therapeutics, Inc. Buy 19.6% 0%
CLDX Celldex Therapeutics, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 41.2%
New Assets Added
  • RMD
  • NTLA
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2021-02-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 8.81%
Assets Rebalanced
None
2021-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 19.6% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • BRKR
Assets Removed
None
Assets Rebalanced
None
2021-01-25 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
IART Sell All 5.06%
REGN Sell All 7.83%
Assets Rebalanced
None
2021-01-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IART Integra LifeSciences Holdings Corporation Buy 19.6% 0%
REGN Regeneron Pharmaceuticals, Inc. Buy 19.6% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • IART
  • REGN
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings